If you want to distinguish your goods, services or both from those of another company, you may need a trademark or trade name. Find out what they are, what their registration procedure is and what it involves.
Information on the deadlines for filing applications for transformation of European Union trademarks into Spanish national trademarks. See more
If you have a new device, product or procedure that solves a technical problem or has a practical advantage, there are different ways to protect it in Spain and other countries. Find out how.
Does your innovation lie in the aesthetics, ornamentation or appearance of your product? Protect it through industrial design. Find out what rights registration confers and how to proceed.
Geographical indications protect the name of a product that has a specific geographical origin and owes its qualities, characteristics or reputation to its particular origin. Find out what they are, how the registration process works and what benefits they provide.
Patents published worldwide are a valuable source of scientific, technical and commercial information.
El Bono 3 del Fondo para PYMEs 2025, que cubre la elaboración de Informes Tecnológicos de Patentes (ITP) y Búsquedas Retrospectivas se cerrará el lunes 10 de febrero de 2025 al cierre de la jornada laboral. Próximamente se informará sobre su reapertura. Puede consultar más información aquí.
If you are an entrepreneur or a company and you want to boost and improve the profitability of your business by adequately protecting the intangible assets of your organisation, in this space you will find what you need.
297
results.
Updated on
15/11/2026 [07:34:00]
Results 250 to 275 of 297
Absstract of: CN122955026A
本发明涉及医疗器械技术领域，具体涉及一种心肌补片及其制备方法。心肌补片，其包括叠层设计的基底层和顶层；基底层以三维多孔水凝胶为基体，负载有间充质干细胞或者心肌细胞；顶层以水凝胶为基体，其表面设计有微沟槽阵列，微沟槽中接种心肌细胞。本发明提供的心肌补片通过设定三维多孔的基底层为组织再生提供临时力学支撑，整体的宏观压缩模量稳定在10~60 kPa，与天然心肌动态力学特性高度匹配，可适应心脏周期性搏动，避免应力失配引发的组织损伤与术后并发症。此外顶层微沟槽阵列诱导心肌细胞沿沟槽定向排列、同步收缩与功能成熟，实现高效细胞导向与组织整合，同时最大程度保留水凝胶生物活性与细胞相容性。
Absstract of: US20260325089A1
According to one aspect of an exemplary embodiment of the disclosure, an imaging device or system, e.g., a mammography imaging system or device, includes an optimized compression module on the imaging system to provide optimized compression of a breast on the mammography imaging system employing information from one or more sensing device(s) disposed on the mammography imaging system. Examples of the types of sensing devices include force sensors, ultrasound sensing devices, MEMS radar devices and/or time-of-flight (ToF) sensing devices. The information provided by the sensing devices is compared with an optimized compression stop point determined by the optimized compression module for use in controlling movement of various components of the imaging system, e.g., a compression plate, to compress the breast to an optimized position to enhance the quality of images to be obtained of the breast and/or maximizing patient comfort.
Absstract of: WO2022040456A1
Provided herein are systems, devices, and methods to measure auditory signals from a subject to determine a state of a subject. The auditory signals measured may provide a tool to monitor the development of disease state(s) or abnormal physiologic conditions (e.g., wheezing, fluid accumulation, abnormal heart murmur or rhythm, etc).
Absstract of: US20220339383A1
0001 Method and apparatus obtain information about a patient and/or a respiratory therapy system that is configured to deliver respiratory therapy to the patient. The respiratory therapy system may include a flow generator configured to generate a supply of pressurized air along an air circuit to a patient interface. A sound signal representing a sound in the air circuit may be processed to obtain cepstrum data. A time series of delay estimates based on acoustic signatures of the cepstrum data may be generated. Each acoustic signature may represent a reflection of sound from a patient interface along the air circuit. Variation in the time series of delay estimates may be analysed. One or more output indicators based on the variation may be generated. The one or more output indicators may concern patient and/or system status.
Absstract of: WO2023168284A1
Disclosed herein is a combination of an automated insulin delivery system and a continuous glucose monitor integrated into a single, wearable package. The system may use any combination of delivery methods and detection methods, wherein the delivery methods include a cannula, a microneedle array, and a transdermal patch, and wherein the detection methods include electrochemical methods, opto-fluorescent methods, and spectrographic methods.
Absstract of: WO2025231022A1
A system may include a flow sensor and/or a base. The flow sensor may include a sensor to detect a property of a medical device received by the system. The base may be configured to receive the flow sensor. The base may include a stabilizing surface; a monitoring surface rotatable at least 90 degrees relative to the stabilizing surface, the monitoring surface including a reflective portion; and a sensor mount rotatable at least 90 degrees relative to the monitoring surface and including: means to secure the flow sensor to the sensor mount; and a sensor channel adapted provide a field of detection for the sensor through the sensor mount toward the reflective portion.
Absstract of: US20260325773A1
The present disclosure provides for a control system for a flow therapy apparatus. The control system can control delivery of a fraction of delivered oxygen (FdO2) to a patient. The control system can maintain the FdO2 at a target level during a therapy session. The control system can automatically control an oxygen inlet valve in order to control the flow of oxygen to the patient.
Absstract of: US20260331252A1
A computer-implemented method is disclosed. The method includes determining whether one or more messages have been received while a user performs a treatment plan. The one or more messages may pertain to at least one of a user and a usage of the electromechanical machine by the user. The electromechanical machine may be configured to be manipulated by the user while the user is performing a treatment plan. The method also includes, responsive to determining that the one or more messages have not been received, determining, using one or more machine learning models, one or more preventative actions to perform. The method also includes causing the one or more preventative actions to be performed.
Absstract of: US20260325019A1
Systems and methods for wireless communication of analyte information are disclosed. Example embodiments include an analyte sensor system. The analyte sensor system may include an analyte sensor to gather information related to a level of an analyte in a host. The analyte sensor system may include circuitry to transmit and receive wireless signals using a first antenna. The analyte sensor may be coupled to the circuitry before the analyte sensor system is transitioned into an operational state. The analyte sensor system may include a second antenna to receive an input signal from a source external to the analyte sensor system and to transmit a modified signal. The circuitry may use the first antenna to receive the modified signal The analyte sensor system may transition into the operational state in response to the modified signal received using the first antenna.
Absstract of: US20260325244A1
A method for using a control center at a remote site to control operation of a robotic medical device system at a local site includes transmitting a control signal from the control center to the robotic medical device system, determining a delay in transmission of the control signal, comparing the delay to a threshold delay value and operating the robotic medical device system based on the comparison of the delay to the threshold delay value.
Absstract of: US20260325073A1
A device for monitoring a patient includes a substrate, an adhesive layer coupled to a first side of the substrate, and a circuit board coupled to a second side of the substrate. The adhesive layer is configured to adhere to a patient. The device includes a first plurality of input interfaces coupled to the circuit board. The first plurality of input interfaces configured to identify a particular injury location. The device includes a second plurality of input interfaces coupled to the circuit board. The second plurality of input interfaces configured to identify a patient injury type. The device also includes a wireless transmitter coupled to the circuit board. The wireless transmitter is configured to transmit medical information associated with the patient to a mobile device. The medical information includes data indicating a setting of each of the first plurality of input interfaces and the second plurality of input interfaces
Absstract of: US20260325268A1
0000 A method and device for processing oral scanning data, and an apparatus are provided. The method includes: performing a scanning task on a plurality of scan regions in an oral cavity in a preset scanning sequence; obtaining target scanning data of the current scan region when a scanning completion event of the current scan region is monitored; performing a data processing task on the target scanning data when no data processing task is being performed; and performing the scanning task on the next scan region according to the scanning sequence, and determining the next scan region as a new current scan region.
Absstract of: US20260324973A1
0000 Systems, devices, and methods for remote monitoring and managing of patients with chronic pain are discussed. A remote monitoring system comprises a cloud-computing device and a remote device. The cloud-computing device receives patient data including physiological or functional information sensed by sensors, and provides on-demand cloud-based services including establishing a correspondence between one or more physiological or functional states and one or more pain levels, detecting patient physiological or functional state, predicting a pain level, detecting a patient behavior, generating a recommendation for adjusting sensor operations based on the patient behavior, and storing patient data and other information in a cloud storage. The remote device can access the cloud storage and the cloud-based services, provide the stored information to an authorized user or the patient, control an implantable device to initiate or adjust a neuromodulation therapy, or adjust sensor operations.
Absstract of: AU2026242184A1
A medical system useful in the determination of future disease progression in a subject. More specifically the present invention applies machine learning techniques to aid prediction of disease pathology and clinical outcomes in subjects presenting with symptoms of cognitive decline and to expedite clinical development of novel therapeutics. ep e p
Absstract of: US20260331251A1
Aspects of systems and methods for authenticating illuminating medical infusion lines are disclosed. An electronic illuminator for illuminating medical infusion lines includes a fiber detection assembly configured with a three-dimensional magnetic flux density and a microcontroller. A side scattering fiber optic cable includes a fiber funnel cap with a metallic plate at a proximal end and a protective end cap at a distal end. The fiber detection assembly detects a magnetic flux key when the fiber funnel cap is connected to the electronic illuminator. An electronic illuminator is provisioned with a fiber detection assembly configured with a three-dimensional magnetic flux density. A side scattering fiber optic cable with a fiber funnel cap configured with a metallic plate is connected to the electronic illuminator. A change in voltage is detected as the fiber funnel cap is connected, wherein a final voltage results in a magnetic flux key that is authenticated by the MCU against stored parameters.
Absstract of: US20260325224A1
0000 A method and computer programs for guiding an implantable device during a clinical intervention are disclosed. The method comprises a) generating a 3D vasculature model; b) defining a target deployment plan of the device inside the 3D vasculature model; c) obtaining a configuration parameter of the device; d) receiving a live image feed corresponding to a real-time deployment of the device within the 3D vasculature model; e) segmenting the deployed device in the live image feed, and obtaining a point-to-point longitudinal trajectory of the deployed device; f) extracting the same configuration parameter as in step c) from the deployed segmented device; g) determining the trajectory of the deployed segmented device on the generated 3D vasculature model; h) comparing the determined trajectory and configuration parameter of the deployed segmented device with the feasible trajectory and configuration parameter; and i) assessing closeness between the defined target deployment plan and the real-time deployment based on the comparison.
Absstract of: CN120056234A
The invention relates to a method, an apparatus and a system for producing dental prostheses by jet printing. The invention provides a method for producing a dental restoration by jet printing, comprising the steps of: jet printing (S101) one or more layers of a dental restoration by means of a ceramic slurry; and jet printing (S102) a translucency enhancer and/or an opacity enhancer onto the one or more layers.
Absstract of: CN120056233A
The invention relates to a method, an apparatus and a system for producing dental prostheses by jet printing. The invention provides a method for producing a dental restoration by jet printing, comprising the steps of: jet printing (S101) one or more layers of a dental restoration by means of a ceramic slurry; jet printing (S102) a coloring solution onto the one or more layers; and applying (S103) a fixing solution for fixing the coloring solution.
Absstract of: US20260325269A1
A system includes an intraoral scanner comprising one or more light projectors, one or more cameras configured to capture intraoral scan data, and a processor configured to process the intraoral scan data. The system further incudes a first computing device configured to receive the intraoral scan data from the intraoral scanner, generate a virtual 3D surface of at least part of the dental site based on the intraoral scan data, generate a plurality of views of the virtual 3D surface, and transmit the plurality of views of the virtual 3D surface to one or more second computing devices. The system further includes the one or more second computing devices, configured to receive the plurality of views of the virtual 3D surface and display the plurality of views of the virtual 3D surface on a display connected to or integrated in the one or more second computing device(s).
Absstract of: US20260324986A1
Presented herein are related to systems and methods of determining likelihood of vascular conditions using acoustic measurements of veins in limbs of subjects. A pressure cuff may be secured about a region of a limb of a subject, and may apply pressure to the region to compress a vein in the limb. A plurality of sensors may be positioned on the region of the limb. Each sensor may acquire a respective acoustic signal in response to the pressure cuff releasing the pressure to the region. A computing system may receive the plurality of acoustic signals from the plurality of sensors. The computing system may generate, according to the plurality of acoustic signals, a plurality of metrics. The computing system may determine, according to the plurality of metrics, a likelihood of a vascular condition in the vein in the limb of the subject.
Absstract of: US20260325718A1
0000 The disclosure relates to an aqueous bioink solution for use in light-based bioprinting applications, comprising: (a) 0.5-95 wt % water-soluble prepolymer; (b) 0.001-5 wt % biocompatible metal acylphosphinate photoinitiator; (c) 0.001-10 wt % biocompatible light absorber; and (d) 5 to 99.5 wt % solvent. The disclosure further relates to a method of using the aqueous bioink solution including living cells and a method of using the aqueous bioink solution without living cells (acellularly).
Absstract of: US20260325010A1
0000 Aspects are directed to a wearable analyte monitoring device including a microneedle array configured to detect an analyte in interstitial fluid of a user. The wearable analyte monitoring device also includes sensors to determine a state of a user, including for example periods of rest and periods of activity, using one or more signals from the sensors. The sensors include an ambient light sensor, a kinetic sensor, and a clock.
Absstract of: US20260331271A1
0000 The disclosure provide a quality assurance method for performing quality assurance on a radiation delivery system, the method comprising: performing a first quality assurance operation using a quality assurance phantom; and performing a second quality assurance operation using the quality assurance phantom, wherein the first quality assurance operation is one of an imaging quality assurance operation and a machine quality assurance operation, and the second quality assurance operation is the other one of the imaging quality assurance operation and the machine quality assurance operation, and between the first quality assurance operation and the second quality assurance operation, the quality assurance phantom is automatically moved from a first position corresponding to the first operation to a second position corresponding to the second operation, or remains at a fixed position.
Absstract of: US20260325219A1
Described herein is an apparatus and method for determining a cardiac implant size. In some embodiments, an apparatus may include an ultrasonic imaging device, at least a processor, and a memory communicatively connected to the at least a processor, wherein the memory contains instructions configuring the at least a processor to, using the ultrasonic imaging device, collect a plurality of ultrasonic images, using a 3D cardiac model generation machine learning model trained on a training dataset comprising example ultrasonic images correlated with example 3D cardiac models, generate a 3D cardiac model based on the plurality of ultrasonic images, generate at least a cardiac measurement based on the 3D cardiac model, determine a cardiac implant size based on the at least a cardiac measurement, and display to a user the cardiac implant size.
Nº publicación: US20260327455A1 22/10/2026
Applicant:
ELKEM SILICONES FRANCE SAS [FR]
ELKEM SILICONES USA CORP [US]
Elkem Silicones France SAS
ELKEM SILICONES USA Corp.
Absstract of: US20260327455A1
0000 The present invention relates to a method of post-treatment of a 3D-printed silicone article, said method comprising the coating the 3D-printed silicone article with a crosslinkable silicone composition comprising a microfiller. The invention further relates to a crosslinkable silicone composition comprising a microfiller, and its use as post-treatment composition for the post-treatment of a 3D printed silicone article.
BOPI
Electronic site
